The Experience of TYAC Offered Ovarian Tissue Cryopreservation

NCT02830061 | Completed

• 1 other identifier: 12019
• Study Type: observational
• Target: 12
• Locations: 0 countries
• Sites: N/A

Brief Summary

This study looks at the experiences of teenagers and young adults who have been offered ovarian tissue cryopreservation prior to cancer treatment as a result of their cancer and/or cancer treatment putting them at moderate-to-high risk of premature ovarian failure.

Conditions

Cancer; Fertility

Keywords

Cancer; Teenage; Young Adult; Fertility; Cryopreservation; Experience

Outcome Measures

Primary Outcomes (1)

• Individual semi-structured interviews about the experiences of Teenagers and Young Adults with Cancer undergoing OTC

  up to 60 min

Study Arms (1)

TYAC

Teenagers and young adults who have received a cancer diagnosis which puts them at moderate-to-high risk of fertility impairment. Semi-structured interviews will take place with each individual participant.

Other: Interviews

Interventions

Interviews OTHER

Individual semi-structured interviews for 30-60 minutes using an interview schedule developed from an interpretative phenomenological analysis framework.

TYAC

Eligibility Criteria

• Age: 13 Years - 25 Years
• Sex: female
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

TYAC who have been offered OTC due to moderate-to-high risk of premature ovarian failure due to their cancer and/or cancer treatment.

You may qualify if:

• Aged 11-25 at time of procedure and aged 13+ at time of interview. Due to the short amount of time OTC has been available, there will be no time limit on how long ago the procedure took place.
• Received a cancer diagnosis carrying a moderate-high risk of premature ovarian failure as a result of the cancer and/or treatment.
• Have been offered ovarian cryopreservation by the ovarian cryopreservation service (participants will be included whether or not they have accepted the procedure).
• Has been confirmed as appropriate to approach by the consultant oncologist.

You may not qualify if:

• Under the age of 11 or over the age of 25 at time of procedure.
• Under the age of 13 at time of interview.
• Received a terminal diagnosis.
• The young person is unable to understand their diagnosis and/or fertility options, e.g. those with significant learning disabilities (guidance on this will be sought from the consultant oncologist as part of their approval).
• The young person is unaware that the procedure has taken place (guidance on this will be sought from the consultant oncologist as part of their approval).

Sponsors & Collaborators

• University of Oxford: lead
• Oxford University Hospitals NHS Trust: collaborator

MeSH Terms

Conditions

Neoplasms

Interventions

Interviews as Topic

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Rebekah Tennyson, DClinPsy

  Oxford Health NHS Foundation Trust

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 8, 2016
• First Posted: July 12, 2016
• Study Start: July 1, 2016
• Primary Completion: July 1, 2018
• Study Completion: September 1, 2018
• Last Updated: October 24, 2019

Record last verified: 2019-10